ADCT-701 / ADC Therapeutics  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ADCT-701 / ADC Therapeutics
NCT06041516: Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas

Recruiting
1
70
US
ADCT-701
National Cancer Institute (NCI)
Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine, Carcinoma, Adrenocortical, Carcinoma, Adrenal Cortical
10/27
10/29

Download Options